NO20071706L - Koadministrering av Tigecycline og Digoxin. - Google Patents

Koadministrering av Tigecycline og Digoxin.

Info

Publication number: NO20071706L
Authority: NO; Norway
Prior art keywords: tigecycline; digoxin; administration; administered; human
Prior art date: 2004-10-28

Application number

NO20071706A

Other languages

English (en)

Norwegian (no)

Inventor

Donald G Raible

Gopal Muralidharan

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-28

Filing date

2007-03-30

Publication date

2007-05-24

2007-03-30 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-05-24 Publication of NO20071706L publication Critical patent/NO20071706L/no

Links

LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 title abstract 2
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 title abstract 2
229960005156 digoxin Drugs 0.000 title abstract 2
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 title abstract 2
FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 title abstract 2
229960004089 tigecycline Drugs 0.000 title abstract 2
238000011260 co-administration Methods 0.000 title 1
208000035143 Bacterial infection Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

NO20071706A 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin. NO20071706L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62285904P	2004-10-28	2004-10-28
PCT/US2005/038410 WO2006060084A2 (en)	2004-10-28	2005-10-24	Coadministration of tigecycline and digoxin

Publications (1)

Publication Number	Publication Date
NO20071706L true NO20071706L (no)	2007-05-24

Family

ID=36127476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071706A NO20071706L (no)	2004-10-28	2007-03-30	Koadministrering av Tigecycline og Digoxin.

Country Status (18)

Country	Link
US (1)	US20060094668A1 (es)
EP (1)	EP1804807B1 (es)
JP (1)	JP2008518911A (es)
KR (1)	KR20070069182A (es)
CN (1)	CN101039679A (es)
AT (1)	ATE415973T1 (es)
AU (1)	AU2005310306A1 (es)
BR (1)	BRPI0517406A (es)
CA (1)	CA2582089A1 (es)
CR (1)	CR9073A (es)
DE (1)	DE602005011468D1 (es)
EC (1)	ECSP077423A (es)
IL (1)	IL182681A0 (es)
MX (1)	MX2007005163A (es)
NO (1)	NO20071706L (es)
RU (1)	RU2007112409A (es)
WO (1)	WO2006060084A2 (es)
ZA (1)	ZA200703441B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2434944T5 (es)	2005-03-14	2022-10-20	Wyeth Llc	Composiciones de tigeciclina y procedimientos de preparación
PE20070072A1 (es) *	2005-06-16	2007-02-25	Wyeth Corp	Proceso de manufactura para tigeciclina como polvo reconstituible
GB2461037A (en) *	2008-06-17	2009-12-23	Elias Bouras	A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) *	2008-08-06	2010-02-11	Wyeth	Tigecycline formulations
KR20230169457A (ko)	2017-01-27	2023-12-15	뉴로크린 바이오사이언시즈 인코퍼레이티드	특정 vmat2 억제제의 투여 방법
RS66714B1 (sr)	2017-09-21	2025-05-30	Neurocrine Biosciences Inc	Formulacija visoke doze valbenazina i sastavi, postupci i kompleti povezani sa njim
MX2020003421A (es) *	2017-10-10	2020-07-20	Neurocrine Biosciences Inc	Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).

2005
- 2005-10-24 JP JP2007539052A patent/JP2008518911A/ja active Pending
- 2005-10-24 BR BRPI0517406-6A patent/BRPI0517406A/pt not_active IP Right Cessation
- 2005-10-24 RU RU2007112409/14A patent/RU2007112409A/ru not_active Application Discontinuation
- 2005-10-24 AU AU2005310306A patent/AU2005310306A1/en not_active Abandoned
- 2005-10-24 DE DE602005011468T patent/DE602005011468D1/de not_active Expired - Fee Related
- 2005-10-24 AT AT05851251T patent/ATE415973T1/de not_active IP Right Cessation
- 2005-10-24 MX MX2007005163A patent/MX2007005163A/es not_active Application Discontinuation
- 2005-10-24 EP EP05851251A patent/EP1804807B1/en not_active Expired - Lifetime
- 2005-10-24 KR KR1020077009607A patent/KR20070069182A/ko not_active Withdrawn
- 2005-10-24 CA CA002582089A patent/CA2582089A1/en not_active Abandoned
- 2005-10-24 CN CNA2005800350112A patent/CN101039679A/zh active Pending
- 2005-10-24 WO PCT/US2005/038410 patent/WO2006060084A2/en not_active Ceased
- 2005-10-28 US US11/261,259 patent/US20060094668A1/en not_active Abandoned
2007
- 2007-03-30 NO NO20071706A patent/NO20071706L/no not_active Application Discontinuation
- 2007-04-19 IL IL182681A patent/IL182681A0/en unknown
- 2007-04-20 CR CR9073A patent/CR9073A/es not_active Application Discontinuation
- 2007-04-26 ZA ZA200703441A patent/ZA200703441B/xx unknown
- 2007-04-27 EC EC2007007423A patent/ECSP077423A/es unknown

Also Published As

Publication number	Publication date
WO2006060084A2 (en)	2006-06-08
WO2006060084A3 (en)	2006-07-20
US20060094668A1 (en)	2006-05-04
KR20070069182A (ko)	2007-07-02
MX2007005163A (es)	2007-06-26
CR9073A (es)	2007-08-28
RU2007112409A (ru)	2008-12-10
EP1804807A2 (en)	2007-07-11
ECSP077423A (es)	2007-05-30
DE602005011468D1 (de)	2009-01-15
AU2005310306A1 (en)	2006-06-08
CA2582089A1 (en)	2006-06-08
BRPI0517406A (pt)	2008-10-07
ATE415973T1 (de)	2008-12-15
EP1804807B1 (en)	2008-12-03
JP2008518911A (ja)	2008-06-05
ZA200703441B (en)	2008-09-25
IL182681A0 (en)	2007-09-20
CN101039679A (zh)	2007-09-19

Similar Documents

Publication	Publication Date	Title
NO20070988L (no)	2007-05-04	Vaksine for forebygging og behandling av HIV-infeksjon
NO20064547L (no)	2006-10-06	Fremgangsmater for behandling av HIV infeksjon
DK2109602T3 (da)	2014-05-19	Tetracyclinderivater til behandling af bakterielle, virale og parasitiske infektioner
DK1773361T3 (da)	2009-11-16	Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme og/eller infektioner og til forbedring af en intestinale funktionalitet
TN2010000137A1 (en)	2011-09-26	Spiropyrrolidines and their use against hcv and hiv infection
SI1951272T1 (sl)	2016-10-28	Uporaba lactobacillus za zdravljenje virusnih infekcij
NO20074943L (no)	2007-10-01	Roflumilast for behandlingen av diabetes mellitus
EP2192901A4 (en)	2010-10-13	CHEMICAL AGENTS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND RELATED DISEASES
WO2008118849A3 (en)	2008-12-18	Hiv-1 protease inhibitors
DK1638589T3 (da)	2014-06-30	Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
NO20052362D0 (no)	2005-05-12	Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
EA201171186A1 (ru)	2012-05-30	Сокристалл этравирина и никотинамида
UA100702C2 (ru)	2013-01-25	Комбинационная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства - гемцитабина
NO20072285L (no)	2007-06-13	S-mirtazapin for behandling av hetetokter
ZA200703441B (en)	2008-09-25	Coadministration of tigecycline and digoxin
ATE548044T1 (de)	2012-03-15	Kombinationstherapie zur behandlung von hiv- infektionen
DK1919466T3 (da)	2012-07-02	Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
DK1848415T3 (da)	2013-07-08	Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
ZA200802934B (en)	2009-09-30	Use of lactobacillus for treatment of virus infections
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
DK1635847T3 (da)	2019-10-28	Behandling af symptomer forbundet med bakteriel vaginose
NO20080495L (no)	2008-03-10	PEG-IFN-alfa og ribavirin for HBV-behandling
ATE433459T1 (de)	2009-06-15	Desoxo-nonadepsipeptide
EA200970588A1 (ru)	2009-12-30	Способы и композиции для лечения патологий, связанных с опосредуемым il-4 или il-13 фиброзом
IL180459A0 (en)	2007-06-03	Treatment of bacterial infections

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application